Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
ARNOLD
1 other identifier
observational
637
1 country
36
Brief Summary
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2024
Typical duration for all trials
36 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2024
CompletedFirst Posted
Study publicly available on registry
May 23, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 2, 2028
April 20, 2026
December 1, 2025
3 years
April 24, 2024
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of the number of patients with cardiac amyloidosis according bon scintigraphy
At inclusion
Secondary Outcomes (6)
Assessment of commorbidity risk according Charlson Comorbidity Index (CCI)
At inclusion
Assessment of the degree of patient dependence according Katz Index of Independence in Activities of Daily Living (ADL)
At inclusion
Measuring cognitive impairment according Mini-Mental State Examination (MMSE) score
At inclusion
Estimating the probability of neuropathic pain according "DN4 Questionnaire"
At inclusion
Assessment of physical frailty according Fried scale
At inclusion
- +1 more secondary outcomes
Eligibility Criteria
Patients with cardiac amyloidosis expressed by a positive bone scintigraphy.
You may qualify if:
- Aged ≥ 80 years
- Hospitalised for decompensation of heart failure in the last 12 months
- Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
- Subjects able to undergo a bone scintigraphy scan
- Subjects willing to participate
You may not qualify if:
- Subjects refusing to participate
- Subjects admitted to palliative care unit.
- Subjects under guardianship
- Subjects with a definite diagnosis of cardiac amyloidosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gérond'iflead
Study Sites (36)
Geriatric Department, Broca Hospital
Paris, IIe-de-France, 75013, France
CHU Nantes
Nantes, Loire-Atlantique, 44000, France
CHU Poitiers
Poitiers, New Aquitaine, 86000, France
CHU Rouen, Charles Nicole hospital
Rouen, Normandy, 76000, France
CHU Montpellier
Montpellier, Occitanie, 34090, France
CHU Toulouse
Toulouse, Occitanie, 31300, France
CHU Amiens Picardie
Amiens, 80000, France
CHU Angers
Angers, 49100, France
CHU Bordeaux
Bordeaux, 33000, France
Centre Hospitalier de Carcassonne
Carcassonne, 11100, France
Centre Hospitalier Intercommunal de Castres-Mazamet
Castres, 81100, France
CHU Trousseau-Tours
Chambray-lès-Tours, 37170, France
CHU Dijon
Dijon, 21000, France
CHU Grenoble Alpes
Grenoble, 38700, France
CHU Lille
Lille, 59000, France
CHU Limoges
Limoges, 87000, France
CHU Lyon
Lyon, 69002, France
CHU Marseille
Marseille, 13005, France
Clinique du Millénaire-Montpellier
Montpellier, 34000, France
CHRU Nancy
Nancy, 54000, France
CHU Nice
Nice, 06000, France
Hôpital Privé Gériatrique LES SOURCES-Nice
Nice, 06100, France
CHU Orléans
Orléans, 45100, France
CHU Rennes
Rennes, 35000, France
CHRU Tours-Bretonneau Hospital
Tours, 37000, France
Clinique Saint Joseph Trelaze
Trélazé, 49800, France
Médipôle Hôpital Mutualiste Villeurbanne
Villeurbanne, 69100, France
Ambroise Paré Hospital
Boulogne-Billancourt, Île-de-France Region, 92100, France
Corentin Celton Hospital
Issy-les-Moulineaux, Île-de-France Region, 92130, France
Charles Foix Hospital
Ivry-sur-Seine, Île-de-France Region, 94200, France
Emile Roux Hospital
Limeil-Brévannes, Île-de-France Region, 94450, France
GH Sud Ile-de-France
Melun, Île-de-France Region, 77000, France
Lariboisière Hospital
Paris, Île-de-France Region, 75010, France
Saint Joseph Hospital
Paris, Île-de-France Region, 75014, France
Europeen Georges Pompidou Hospital
Paris, Île-de-France Region, 75015, France
Bretonneau Hospital
Paris, Île-de-France Region, 75018, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Olivier Hanon, MD PhD
Geriatric Department, Broca hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2024
First Posted
May 23, 2024
Study Start
July 1, 2024
Primary Completion (Estimated)
July 2, 2027
Study Completion (Estimated)
February 2, 2028
Last Updated
April 20, 2026
Record last verified: 2025-12